Chromosomal Microarray Reinterpretation: Applications to Pediatric Practice - 24/03/22

Abstract |
Chromosomal microarray analysis (CMA) frequently yields inconclusive results. We reexamined inconclusive CMA results from 33 previously tested patients and reached a definitive diagnosis in 3 (9.1%) and identified the need for additional testing in 4 (12.1%). Reinterpretation may resolve inconclusive CMA results.
Le texte complet de cet article est disponible en PDF.Abbreviations : AOH, CMA, CNV, VUS
Plan
| J.P. serves on the scientific advisory board of HU Group Holdings (formerly Miraca Holdings); Baylor Genetics and SRL Labs are subsidiaries that provide genomic testing services. The other authors declare no conflicts of interest. |
|
| Preliminary data were presented as a poster at the 2021 ACMG Annual Clinical Genetics Meeting (13-16 April 2021, Virtual). |
Vol 243
P. 219-223 - avril 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
